HC reserves order on Novartis-Cipla drug dispute
The Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease.
Dec 17, 2014, 21:32 PM IST